Ovarian cancer test comes under fire (OvPlex/Healthlinx/Australia) media article

OvPlex also available (according to article) in Britain/Singapore

Merger of Cancer Australia and NBOCC will unify efforts to address increasing cancer rates

15 June 2010

"The Australian Government’s planned amalgamation of Cancer Australia and the National Breast and Ovarian Cancer Centre (NBOCC) should consolidate efforts to address the nation’s escalating cancer incidence rates, Cancer Council Australia and the Clinical Oncological Society of Australia (COSA) said today (15 June)...."

Trials to detect early ovarian cancer - The West Australian (media report)

Cancer gene patent faces legal challenge - BRCA patients/Australia

"...A legal challenge to the validity of an Australian patent for breast and ovarian cancer genes will be launched in the Federal Court on Tuesday.

The patent for the BRCA1 and BRCA2 genes, which make women more suceptible to the cancers, is owned by American biotechnology company Myriad Genetics. Melbourne-based company Genetic Technologies Limited (GTL) has the exclusive licence from Myriad to carry out testing for the genes in Australia. But law firm Maurice Blackburn is filing a case in the Federal Court in Sydney, challenging the right of the companies to hold exclusive rights to the gene...."

FDA Approval For Dendreon Provenge Immunotherapy Vaccine - pharma news/Australia "CVac"

"Dendreon is using cancer immunotherapies that use the patient's own immune system to treat cancer and the approval of Provenge represents a scientific and clinical advancement for the treatment of prostate cancer.

Prima BioMed, an Australian biotechnology firm focused on cancer immunotherapy, is using the technology to develop its CVac immunotherapy cancer vaccine for the treatment of ovarian cancer."

International Cancer Genome Consortium

Note: those studying ovarian cancer -  

Ovarian Cancer Australia

Ovarian Cancer United States

"Once thought of as a single disease, cancer is now understood to be the result of genetic mutations in cells which disrupt normal functions leading to uncontrollable growth. Because mutations are often specific to a particular type or stage of cancer, systematically mapping the changes that occur in each cancer could provide the foundation for research to identify new therapies, diagnostics and preventive strategies."

$1.25m boost for cancer fight (ovarian) Melbourne, Australia news article

website: Australian Society of Gynaecologic Oncologists ASGO

Australia: Consumer medicine information

Mental health and occupational wellbeing of Australian gynaecologic oncologists

Conclusion:"Australian gynaecologic oncologists experience considerable occupational distress while possessing high levels of personal accomplishment and job satisfaction. To maintain a healthy workforce, it is important to build on existing supports while conducting further research to identify suitable evidence-based strategies for improving the mental health of these surgeons."

Australian public service announcement - ovarian cancer on Youtube